Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Verri · SciRah

Researcher profile · Semantic Scholar

E. Verri

Share profile

E. Verri — researcher profile on SciRah

h-index: 21
Works: 102
Citations: 1,992

Most-cited papers

Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications
G. Aurilio, A. Cimadamore, R. Mazzucchelli, A. López-Beltran +6 more
2020Cells232 citations Open access
Semantic Scholar
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial
M. Ghi, A. Paccagnella, D. Ferrari, P. Foa +33 more
2017Annals of Oncology190 citations Open access
Semantic Scholar
Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications.
F. Nolè, E. Munzone, L. Zorzino, I. Minchella +8 more
2008Annals of Oncology185 citations Open access
Semantic Scholar
Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
R. Iacovelli, F. Nolè, E. Verri, G. Renne +8 more
2016Targeted oncology176 citations
Semantic Scholar
HER2/neu Oncoprotein Overexpression in Epithelial Ovarian Cancer: Evaluation of its Prevalence and Prognostic Significance
E. Verri, P. Guglielmini, M. Puntoni, L. Perdelli +5 more
2005Oncology155 citations
Semantic Scholar
Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer
E. Botteri, M. Sandri, V. Bagnardi, E. Munzone +11 more
2010Breast Cancer Research and Treatment78 citations Open access
Semantic Scholar
Hormone‐receptor expression and activity of trastuzumab with chemotherapy in HER2‐positive advanced breast cancer patients
F. Montemurro, V. Rossi, Maria Cossu Rocca, R. Martinello +9 more
2012Cancer70 citations Open access
Semantic Scholar
Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).
M. Ghi, A. Paccagnella, D. Ferrari, P. Foa +16 more
201467 citations
Semantic Scholar
Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer.
G. Sanna, L. Preda, R. Bruschini, M. C. Rocca +6 more
2006Annals of Oncology62 citations Open access
Semantic Scholar
Participation in Clinical Trials as Viewed by the Patient: Understanding Cultural and Emotional Aspects Which Influence Choice
C. Catania, T. De Pas, A. Goldhirsch, D. Radice +6 more
2008Oncology56 citations
Semantic Scholar
First‐Line PAzopanib in NOn–clear‐cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study
S. Buti, M. Bersanelli, F. Maines, G. Facchini +16 more
2017Clinical Genitourinary Cancer53 citations
Semantic Scholar
Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer
F. Nolè, D. Crivellari, R. Mattioli, G. Pinotti +5 more
2009Cancer Chemotherapy and Pharmacology42 citations
Semantic Scholar
Brain metastases in patients with advanced breast cancer.
G. Sanna, L. Franceschelli, N. Rotmensz, E. Botteri +11 more
2007Anticancer Research42 citations
Semantic Scholar
On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2
O. Caffo, V. Zagonel, C. Baldessari, A. Berruti +16 more
2020Annals of Oncology35 citations Open access
Semantic Scholar
The incidence and relative risk of cardiovascular toxicity in patients treated with new hormonal agents for castration-resistant prostate cancer.
R. Iacovelli, E. Verri, Maria Cossu Rocca, G. Aurilio +3 more
2015European Journal of Cancer34 citations
Semantic Scholar
Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
V. Rossi, F. Nolè, S. Redana, L. Adamoli +7 more
2014Breast28 citations Open access
Semantic Scholar
Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: a mono-institutional case-series report.
E. Munzone, A. Di Pietro, A. Goldhirsch, I. Minchella +7 more
2010Breast27 citations Open access
Semantic Scholar
Capecitabine/vinorelbine: an effective and well-tolerated regimen for women with pretreated advanced-stage breast cancer.
F. Nolè, C. Catania, E. Munzone, A. Rocca +7 more
2006Clinical Breast Cancer27 citations
Semantic Scholar
Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy
D. Alterio, E. d’Ippolito, B. Vischioni, P. Fossati +20 more
2020Acta oncologica26 citations Open access
Semantic Scholar
A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826).
M. Ghi, A. Paccagnella, D. Ferrari, P. Foa +16 more
201325 citations
Semantic Scholar
Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
G. Marvaso, G. Corrao, O. Oneta, M. Pepa +19 more
2021Clinical and Translational Oncology22 citations
Semantic Scholar
Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer
O. Caffo, D. Gasparro, G. Di Lorenzo, A. D. Volta +21 more
2020European Journal of Cancer20 citations Open access
Semantic Scholar
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
O. Caffo, C. Ortega, F. Nolè, D. Gasparro +36 more
2021European Journal of Cancer18 citations
Semantic Scholar
Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views
G. Aurilio, M. Santoni, F. Massari, A. Cimadamore +5 more
2021Cancers17 citations Open access
Semantic Scholar
Prognostic value of circulating tumor cells in primary and metastatic breast cancer
G. Aurilio, A. Sciandivasci, E. Munzone, M. Sandri +5 more
2012Expert Review of Anticancer Therapy17 citations
Semantic Scholar
Emerging treatment landscape of non-muscle invasive bladder cancer
C. Valenza, G. Antonarelli, F. Giugliano, G. Aurilio +4 more
2022Expert Opinion on Biological Therapy15 citations Open access
Semantic Scholar
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin.
R. Iacovelli, C. Ciccarese, M. Brunelli, N. Battelli +17 more
2022Annals of Oncology15 citations Open access
Semantic Scholar
Impact of a dedicated radiologist as a member of the head and neck tumour board: a single-institution experience
D. Alterio, L. Preda, S. Volpe, C. Giannitto +14 more
2020Acta otorhinolaryngologica italica15 citations Open access
Semantic Scholar
First-Line Therapy For Advanced Non-Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
F. Petrelli, E. Verri, A. Ghidini, I. Vavassori +3 more
2025JAMA Oncology14 citations
Semantic Scholar
Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting
P. Bossi, D. Cortinovis, Maria Cossu Rocca, F. Roila +8 more
2016Journal of Alternative and Complementary Medicine14 citations Open access
Semantic Scholar
Narrative review: update on immunotherapy and pathological features in patients with bladder cancer
G. Aurilio, A. Cimadamore, A. López-Beltran, M. Scarpelli +5 more
2021Translational Andrology and Urology13 citations Open access
Semantic Scholar
Prognostic role of the cumulative toxicity in patients affected by metastatic renal cells carcinoma and treated with first-line tyrosine kinase inhibitors
R. Iacovelli, E. Verri, Maria Cossu Rocca, G. Aurilio +3 more
2017Anti-Cancer Drugs13 citations
Semantic Scholar
Modified-BEP Chemotherapy in Patients With Germ-Cell Tumors Treated at a Comprehensive Cancer Center
G. Aurilio, E. Verri, S. Frassoni, V. Bagnardi +11 more
2020American Journal of Clinical Oncology11 citations
Semantic Scholar
Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents.
R. Iacovelli, E. Verri, Maria Cossu Rocca, G. Aurilio +4 more
2016Critical reviews in oncology/hematology11 citations
Semantic Scholar
Fulvestrant in heavily pre-treated patients with advanced breast cancer: results from a single compassionate use programme centre
C. Catania, G. Ascione, L. Adamoli, T. De Pas +8 more
2007Breast Cancer Research and Treatment11 citations
Semantic Scholar
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study
S. Di Cosimo, B. Tagliaferri, D. Generali, F. Giudici +30 more
2021Cancers10 citations Open access
Semantic Scholar
Three-dimensional conformal postoperative radiotherapy in patients with parotid tumors: 10 years' experience at the European Institute of Oncology.
D. Alterio, B. Jereczek-Fossa, M. Griseri, A. d'Onofrio +9 more
2011Tumori9 citations
Semantic Scholar
Cisplatin, Etoposide and Continuous Infusion Bleomycin in Patients with Testicular Germ Cell Tumors: Efficacy and Toxicity Data from a Retrospective Study
G. Curigliano, G. Spitaleri, E. Magni, K. Lorizzo +11 more
2009Journal of chemotherapy9 citations
Semantic Scholar
A phase II trial of dacarbazine (DTIC) and bevacizumab in patients with metastatic melanoma
E. Munzone, A. Testori, I. Minchella, M. Mosconi +6 more
20079 citations
Semantic Scholar
The effect of a treatment delay on outcome in metastatic renal cell carcinoma.
R. Iacovelli, L. Galli, U. de Giorgi, C. Porta +19 more
2019Urologic oncology8 citations
Semantic Scholar
Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica.
G. Banna, N. Nicolai, G. Palmieri, M. Ottaviano +38 more
2019Critical reviews in oncology/hematology8 citations Open access
Semantic Scholar
Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer.
G. Aurilio, M. Sandri, G. Pruneri, L. Zorzino +10 more
2016Future Oncology8 citations
Semantic Scholar
Underuse of Anthracyclines in Women with HER-2+ Advanced Breast Cancer
F. Montemurro, V. Rossi, F. Nolè, S. Redana +9 more
2010The Oncologist8 citations Open access
Semantic Scholar
Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone
F. Mistretta, S. Luzzago, A. Conti, E. Verri +15 more
2022Cancers7 citations Open access
Semantic Scholar
Insertion of a testicular prosthesis at the time of radical orchiectomy for testicular cancer is safe in patients who will subsequently undergo chemotherapy or radiotherapy
G. Musi, G. Cozzi, F. Mistretta, V. Tringali +6 more
2020Andrologia7 citations Open access
Semantic Scholar
Vinorelbine-based chemotherapy in hormone-refractory prostate cancer.
M. Zampino, E. Verri, M. Locatelli, G. Curigliano +9 more
2006Anticancer Research7 citations
Semantic Scholar
Image-Guided Ablations in Patients with Recurrent Renal Cell Carcinoma
G. Aurilio, G. Mauri, Duccio Rossi, P. Della Vigna +8 more
2023Journal of Clinical Medicine6 citations Open access
Semantic Scholar
A phase II open-label study of cabozantinib after first-line treatment including an immune-checkpoint combination in patients with advanced or unresectable renal cell carcinoma: The BREAKPOINT trial (MeetUro trial 03 - EudraCT number 2018-000582-36).
G. Procopio, C. Pircher, M. Claps, V. Guadalupi +13 more
20216 citations
Semantic Scholar
Penile-sparing surgery for patients with superficial or initially invasive squamous cell carcinoma of the penis: long-term oncological outcomes.
S. Luzzago, A. Serino, G. Aurilio, F. Mistretta +15 more
2021Urologic oncology6 citations
Semantic Scholar
Updated survival analyses of a multicentric phase II randomized trial of docetaxel (D) plus enzalutamide (E) versus docetaxel (D) as first-line chemotherapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) (CHEIRON study)
O. Caffo, E. Palesandro, F. Nolè, D. Gasparro +16 more
2019Annals of Oncology6 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Nolè×31
Invite
F. Nolè — researcher profile on SciRah
G. Aurilio×14
Invite
G. Aurilio — researcher profile on SciRah
A. Goldhirsch×13
Invite
A. Goldhirsch — researcher profile on SciRah
L. Adamoli×12
Invite
L. Adamoli — researcher profile on SciRah

×12

Invite

M. C. Rocca — researcher profile on SciRah

Maria Cossu Rocca×10

Invite

Maria Cossu Rocca — researcher profile on SciRah

R. Iacovelli×9

Invite

R. Iacovelli — researcher profile on SciRah

O. de Cobelli×9

Invite

O. de Cobelli — researcher profile on SciRah

Invite

E. Munzone — researcher profile on SciRah

B. Jereczek-Fossa×8

Invite

B. Jereczek-Fossa — researcher profile on SciRah

Invite

D. Cullurà — researcher profile on SciRah

Invite

M. Santoni — researcher profile on SciRah